{
    "title": "Regeneron says early trials promising for Covid-19 treatment",
    "url": "https://www.dailymail.co.uk/wires/afp/article-8787437/Regeneron-says-early-trials-promising-Covid-19-treatment.html",
    "date": "2020-09-29",
    "keywords": [
        "trial",
        "virus",
        "covid19",
        "regeneron",
        "antibody",
        "drug",
        "response",
        "phase",
        "print",
        "firm",
        "cocktail",
        "treatment",
        "immune",
        "year",
        "protein",
        "sarscov2",
        "front",
        "particle",
        "coronavirus",
        "load",
        "recovery",
        "time",
        "robust",
        "nature",
        "george",
        "companys",
        "president",
        "officer",
        "highdose",
        "placebo",
        "benefit",
        "regncov2",
        "substitute",
        "absence",
        "latestage",
        "use",
        "prophylaxis",
        "system",
        "work",
        "body",
        "blood",
        "plasma",
        "convalescent",
        "mass",
        "scale",
        "multiantibody",
        "strategy",
        "order",
        "action",
        "approach",
        "company",
        "study",
        "science",
        "tripleantibody",
        "ebola",
        "race",
        "vaccine",
        "portion",
        "group",
        "approval",
        "end"
    ],
    "category": [
        "wires",
        "afp"
    ]
}